Skip to main content

Table 3 MDA coverage by method and round (Arm A), December 2016–December 2018.

From: Impact of population based indoor residual spraying with and without mass drug administration with dihydroartemisinin-piperaquine on malaria prevalence in a high transmission setting: a quasi-experimental controlled before-and-after trial in northeastern Uganda

Coverage by dose and method

Round (month, year)

Round 1, Dec 2016 n (%)

Round 2, Aug 2017 n (%)

Round 3, Apr 2018 n (%)

Round 4, Dec 2018 n (%)

Dose 1

    

 Fixed distribution

12,536 (80.0)

12,586 (83.0)

12,366 (80.0)

12,449 (80.2)

Dose 2

    

 Door-to-door monitoring

NA

12,412 (81.8)

12,344 (79.8)

12,399 (79.9)

Dose 3

    

 Door-to-door monitoring

NA

12,408 (81.8)

12,343 (79.8)

12,399 (79.9)

Total (N)

15,668

15,170

15,460

15,525

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us